# A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes

> **NCT04712266** · EARLY_PHASE1 · COMPLETED · sponsor: **Abvance Therapeutics** · enrollment: 15 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus With Hypoglycemia

## Interventions

- **DRUG:** Glucagon
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT04712266
- **Lead sponsor:** Abvance Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-01-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04712266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04712266, "A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04712266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*